↓ Skip to main content

Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved…

Overview of attention for article published in BMC Infectious Diseases, September 2011
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
77 Dimensions

Readers on

mendeley
121 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome
Published in
BMC Infectious Diseases, September 2011
DOI 10.1186/1471-2334-11-261
Pubmed ID
Authors

Annette C Reboli, Andrew F Shorr, Coleman Rotstein, Peter G Pappas, Daniel H Kett, Haran T Schlamm, Arlene L Reisman, Pinaki Biswas, Thomas J Walsh

Abstract

Candida albicans is the most common cause of candidemia and other forms of invasive candidiasis. Systemic infections due to C. albicans exhibit good susceptibility to fluconazole and echinocandins. However, the echinocandin anidulafungin was recently demonstrated to be more effective than fluconazole for systemic Candida infections in a randomized, double-blind trial among 245 patients. In that trial, most infections were caused by C. albicans, and all respective isolates were susceptible to randomized study drug. We sought to better understand the factors associated with the enhanced efficacy of anidulafungin and hypothesized that intrinsic properties of the antifungal agents contributed to the treatment differences.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 121 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 <1%
Unknown 120 99%

Demographic breakdown

Readers by professional status Count As %
Researcher 19 16%
Student > Master 15 12%
Other 12 10%
Student > Bachelor 8 7%
Student > Ph. D. Student 7 6%
Other 37 31%
Unknown 23 19%
Readers by discipline Count As %
Medicine and Dentistry 54 45%
Pharmacology, Toxicology and Pharmaceutical Science 11 9%
Agricultural and Biological Sciences 11 9%
Immunology and Microbiology 4 3%
Unspecified 3 2%
Other 9 7%
Unknown 29 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 February 2012.
All research outputs
#15,241,801
of 22,662,201 outputs
Outputs from BMC Infectious Diseases
#4,429
of 7,635 outputs
Outputs of similar age
#91,309
of 131,682 outputs
Outputs of similar age from BMC Infectious Diseases
#63
of 92 outputs
Altmetric has tracked 22,662,201 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 7,635 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one is in the 33rd percentile – i.e., 33% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 131,682 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 18th percentile – i.e., 18% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 92 others from the same source and published within six weeks on either side of this one. This one is in the 19th percentile – i.e., 19% of its contemporaries scored the same or lower than it.